-+ 0.00%
-+ 0.00%
-+ 0.00%

Phathom Pharmaceuticals shareholders elected Class I directors at annual meeting

PUBT·05/21/2026 20:01:54
Listen to the news
Phathom Pharmaceuticals shareholders elected Class I directors at annual meeting
  • Phathom Pharmaceuticals held its annual shareholder meeting on May 19, 2026.
  • Shareholders ratified Ernst & Young as the independent registered public accounting firm for fiscal 2026.
  • Shareholders re-elected three directors to three-year terms running to the 2029 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phathom Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-234379), on May 21, 2026, and is solely responsible for the information contained therein.